Catalyst Wire Dossier Catalyst Wire Dossier

JOBEVNE

Bevacizumab-NWGD · Biocon Biologics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JOBEVNE, covering 2025-04-09 to 2025-04-09. Get the full timeline:

Most recent: FDA Approved: JOBEVNE — Original Application (Biocon Biologics Inc.)

See pricing